Our additional analysis of liver metastases from patients with stage IV CRC further suggests that the observed increase in Gas6-expressing neutrophils in response to chemotherapy might not be restricted to pancreatic cancer metastasis, but may also occur in other cancers that metastasise to the liver. The gene discussed is GAS6; the disease is cancer.